Imiquimod in human CD8+ T cells
Ontology highlight
ABSTRACT: Blood CD8 T cells from six healthy blood donors were treated with the TLR7 agonist imiquimod + IL-2 in T cell enriched medium overnight in vitro (the controls were incubated with T cell enriched medium + IL-2 only). After approx. 21 h the in solution digest protocol was started.
INSTRUMENT(S): Orbitrap Exploris 480
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): T Cell, Blood
SUBMITTER: Prerana Wagle
LAB HEAD: Mario Fabri
PROVIDER: PXD038621 | Pride | 2024-04-29
REPOSITORIES: Pride
ACCESS DATA